Related references
Note: Only part of the references are listed.1-Hydroxypyrene mediates renal fibrosis through aryl hydrocarbon receptor signalling pathway
Hua Miao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Protocatechualdehyde protects oxygen-glucose deprivation/reoxygenation-induced myocardial injury via inhibiting PERK/ATF6α/IRE1α pathway
Yan-Jun Wan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Evaluation of the Therapeutic Effects of Protocatechuic Aldehyde in Diabetic Nephropathy
Yu-Teng Chang et al.
TOXINS (2021)
Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis
Shan-Shan Li et al.
FRONTIERS IN PHARMACOLOGY (2021)
Mitochondrial Redox Signaling and Oxidative Stress in Kidney Diseases
Ana Karina Aranda-Rivera et al.
BIOMOLECULES (2021)
Decoding myofibroblast origins in human kidney fibrosis
Christoph Kuppe et al.
NATURE (2021)
Protocatechualdehyde attenuates obstructive nephropathy through inhibiting lncRNA9884 induced inflammation
Jieke Yang et al.
PHYTOTHERAPY RESEARCH (2021)
Small molecule inhibitors of epithelial-mesenchymal transition for the treatment of cancer and fibrosis
Ya-Long Feng et al.
MEDICINAL RESEARCH REVIEWS (2020)
Identification of endogenous 1-aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation
Hua Miao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Poricoic acid A activates AMPK to attenuate fibroblast activation and abnormal extracellular matrix remodelling in renal fibrosis
Dan-Qian Chen et al.
PHYTOMEDICINE (2020)
New Insights Into the Role and Mechanism of Partial Epithelial-Mesenchymal Transition in Kidney Fibrosis
Lili Sheng et al.
FRONTIERS IN PHYSIOLOGY (2020)
Novel poricoic acids attenuate renal fibrosis through regulating redox signalling and aryl hydrocarbon receptor activation
Wang Ming et al.
PHYTOMEDICINE (2020)
Poricoic acid A as a modulator of TPH-1 expression inhibits renal fibrosisviamodulating protein stability of β-catenin and β-catenin-mediated transcription
Dan-Qian Chen et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2020)
Alisol B 23-acetate attenuates CKD progression by regulating the renin-angiotensin system and gut-kidney axis
Hua Chen et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2020)
Protocatechualdehyde reduces myocardial fibrosis by directly targeting conformational dynamics of collagen
Yan-Jun Wan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan
Dan-Qian Chen et al.
NATURE COMMUNICATIONS (2019)
Neuroprotective effects of protocatechuic aldehyde through PLK2 / p-GSK3β/Nrf2 signaling pathway in both in vivo and in vitro models of Parkinson's disease
Chao Guo et al.
AGING-US (2019)
Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis
Ming Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Targeting TGF-β Signaling in Kidney Fibrosis
Yoshitaka Isaka
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Natural products for the prevention and treatment of kidney disease
Dan-Qian Chen et al.
PHYTOMEDICINE (2018)
Mitochondrial energetics in the kidney
Pallavi Bhargava et al.
NATURE REVIEWS NEPHROLOGY (2017)
The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis
Yu Bo Yang Sun et al.
DIFFERENTIATION (2016)
Protocatechuic Aldehyde Attenuates Cisplatin-Induced Acute Kidney Injury by Suppressing Nox-Mediated Oxidative Stress and Renal Inflammation
Li Gao et al.
FRONTIERS IN PHARMACOLOGY (2016)
Origin of myofibroblasts and cellular events triggering fibrosis
Matthias Mack et al.
KIDNEY INTERNATIONAL (2015)
Amelioration of Bleomycin-induced Pulmonary Fibrosis of Rats by an Aldose Reductase Inhibitor, Epalrestat
Xianwei Li et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2015)
Real-Time Localization of Parathyroid Adenoma during Parathyroidectomy
Jagadeesan Jayender et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Protocatechuic aldehyde ameliorates experimental pulmonary fibrosis by modulating HMGB1/RAGE pathway
Liang Zhang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy
Jay D. Raman et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Protocatechuic Aldehyde Protects against Experimental Sepsis In Vitro and In Vivo
Yong Xu et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2012)
Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy
N. Hotta et al.
DIABETIC MEDICINE (2012)
Protocatechuic Aldehyde Inhibits Lipopolysaccharide-induced Human Umbilical Vein Endothelial Cell Apoptosis via Regulation of Caspase-3
Ya-Ling Xing et al.
PHYTOTHERAPY RESEARCH (2012)
被撤回的出版物: Antifibrotic effects of protocatechuic aldehyde on experimental liver fibrosis (Retracted article. See vol. 51, pg. 675, 2013)
Chunmei Li et al.
PHARMACEUTICAL BIOLOGY (2012)
In Vitro Antioxidant and Anti-Inflammatory Activities of Protocatechualdehyde Isolated from Phellinus gilvus
Zhi-Qiang Chang et al.
JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY (2011)
Resolved: EMT Produces Fibroblasts in the Kidney
Michael Zeisberg et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Mechanistic connection between inflammation and fibrosis
Soo Bong Lee et al.
KIDNEY INTERNATIONAL (2010)
A reduction of unilateral ureteral obstruction-induced renal fibrosis by a therapy combining valsartan with aliskiren
Wen-Pyng Wu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis
M. J. Wu et al.
KIDNEY INTERNATIONAL (2006)
Mechanisms of Disease: fibroblasts - a new look at an old problem
EG Neilson
NATURE CLINICAL PRACTICE NEPHROLOGY (2006)
Renal fibrosis: New insights into the pathogenesis and therapeutics
YH Liu
KIDNEY INTERNATIONAL (2006)
Characterization of renal interstitial fibroblast-specific protein 1/S100A4-positive cells in healthy and inflamed rodent kidneys
M Le Hir et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2005)
Aldose reductase inhibitors from the fruiting bodies of Ganoderma applanatum
S Lee et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Inhibitory effects of Ganoderma applanatum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues
SH Jung et al.
PHYTOTHERAPY RESEARCH (2005)
Protocatechuic aldehyde suppresses TNF-α-induced ICAM-1 and VCAM-1 expression in human umbilical vein endothelial cells
Z Zhou et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention
YH Liu
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Share Paper
